Literature DB >> 17309394

Impact of meningococcal C conjugate vaccine use in Australia.

Robert Booy, Jane Jelfs, Haitham El Bashir, Michael D Nissen.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17309394     DOI： 10.5694/j.1326-5377.2007.tb00828.x

Source DB:  PubMed          Journal:  Med J Aust        ISSN： 0025-729X            Impact factor:   7.738


× No keyword cloud information.
  9 in total

1.  Evaluation of Meningococcal Serogroup C Bactericidal Antibodies after Primary Vaccination: A Multicentre Study, Italy.

Authors:  Arianna Neri; Massimo Fabiani; Anna Maria Barbui; Caterina Vocale; Alessandro Miglietta; Cecilia Fazio; Anna Carannante; Annapina Palmieri; Paola Vacca; Luigina Ambrosio; Paola Stefanelli
Journal:  Vaccines (Basel)       Date:  2022-05-14

2.  New South Wales annual vaccine-preventable disease report, 2013.

Authors:  Alexander Rosewell; Paula Spokes; Robin Gilmour
Journal:  Western Pac Surveill Response J       Date:  2015-04-22

3.  New South Wales annual vaccine-preventable disease report, 2012.

Authors:  Alexander Rosewell; Paula Spokes; Robin Gilmour
Journal:  Western Pac Surveill Response J       Date:  2014-06-30

4.  Safety and immunogenicity of an investigational quadrivalent meningococcal conjugate vaccine after one or two doses given to infants and toddlers.

Authors:  S A Halperin; F Diaz-Mitoma; P Dull; A Anemona; F Ceddia
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2009-12-22       Impact factor: 3.267

5.  Meningococcal conjugate vaccines: optimizing global impact.

Authors:  Andrew Terranella; Amanda Cohn; Thomas Clark
Journal:  Infect Drug Resist       Date:  2011-09-21       Impact factor: 4.003

6.  Serogroup C meningococci in Italy in the era of conjugate menC vaccination.

Authors:  Paola Stefanelli; Cecilia Fazio; Tonino Sofia; Arianna Neri; Paola Mastrantonio
Journal:  BMC Infect Dis       Date:  2009-08-22       Impact factor: 3.090

7.  Annual vaccine-preventable disease report for New South Wales, Australia, 2014.

Authors:  Nathan Saul; Robin Gilmour; Paula Spokes
Journal:  Western Pac Surveill Response J       Date:  2017-06-26

Review 8.  Global practices of meningococcal vaccine use and impact on invasive disease.

Authors:  Asad Ali; Rabab Zehra Jafri; Nancy Messonnier; Carol Tevi-Benissan; David Durrheim; Juhani Eskola; Florence Fermon; Keith P Klugman; Mary Ramsay; Samba Sow; Shao Zhujun; Zulfiqar Bhutta; Jon Abramson
Journal:  Pathog Glob Health       Date:  2014-01       Impact factor: 2.894

9.  Meningococcal disease before and after the introduction of meningococcal serogroup C conjugate vaccine. Federal District, Brazil.

Authors:  Márcia de Cantuária Tauil; Cleidiane Santos Rodrigues de Carvalho; Ataiza César Vieira; Eliseu Alves Waldman
Journal:  Braz J Infect Dis       Date:  2014-03-31       Impact factor: 3.257
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.